InvestorsHub Logo
icon url

mcsharkey

05/16/16 4:39 PM

#40502 RE: mrbigglessworth #40499

Thinking 56% increase from nuthin' is way too damn cheap Mr. Big! By last quarter report, we have ~24 Million shares in the FLOAT (retail) status.

TRENTON, N.J. (AP) — Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin disorder treatments for about $5.2 billion, weeks after the U.S. Treasury Department torpedoed Pfizer's planned $160 billion deal for Allergan PLC.

Allergen lost a double shit load of cash more than we did last quarter.

If we got bought out for equal total ($5.2B), we're talking about ~$216 pps.

Let's pull it up a little Brother. I can handle that range a lot better than the $3.75 you're mentioning. Tsk tsk tsk
VR
Mike Sharkey